Human BTLA (31-150) (M105V, G138S, V148M) Protein, His Tag (MALS verified), Unconjugated

Produktübersicht

• Artikelname: Human BTLA (31-150) (M105V, G138S, V148M) Protein, His Tag (MALS verified), Unconjugated
• Artikelnummer: ABS-BTA-H52H5-1MG
• Hersteller Artikelnummer: BTA-H52H5-1mg
• Alternativnummer: ABS-BTA-H52H5-1MG
• Hersteller: AcroBiosystems
• Wirt: Human
• Kategorie: Proteine/Peptide
• Spezies Reaktivität: Human
• Konjugation: Unconjugated

Produktbeschreibung

B and Tlymphocyte attenuator (BTLA) is also known as B and Tlymphocyteassociated protein, CD antigen CD272. BTLA contains one Iglike Vtype (immunoglobulinlike) domain. As a lymphocyte inhibitory receptor, BTLA / CD272 inhibits lymphocytes during immune response. BTLA / CD272 can interact with tyrosine phosphatases PTPN6/SHP1 and PTPN11/SHP2, and interact with TNFRSF14/HVEM. - Proteine/Peptide

Produkteigenschaften

• Molekulargewicht: 15.8 kDa
• Tag: C-10*His
• NCBI: 44003
• Puffer: PBS, pH7.4
• Reinheit: 90%
• Formulierung: Powder
• Target-Kategorie: BTLA

Bilder

Immobilized Human BTLA (31-150) (M105V, G138S, V148M), His Tag (Cat. No. BTA-H52H5) at 5 µg/mL (100 µL/well) can bind Human HVEM, Fc Tag (Cat. No. HVM-H5258) with a linear range of 0.6-5 ng/mL (QC tested).

Immobilized Human BTLA (31-150) (M105V, G138S, V148M), His Tag (Cat. No. BTA-H52H5) at 5 µg/mL (100 µL/well) can bind Human HVEM, Mouse IgG2a Fc Tag, low endotoxin with a linear range of 0.6-39 ng/mL (Routinely tested).

BTA-H52H5-1mg

Human BTLA (31-150) (M105V, G138S, V148M), His Tag on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 90%.